NCT04039503 A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin Status COMPLETED Phase PHASE3
NCT04032080 LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer Status COMPLETED Phase PHASE2
NCT04031885 A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer Status TERMINATED Phase PHASE4
NCT04031872 LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615) Status WITHDRAWN Phase PHASE1/PHASE2
NCT04030728 Implementing Patients´ Competence in Oral Breast Cancer Therapy Status UNKNOWN Phase N/A
NCT04023669 Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors Status COMPLETED Phase PHASE1
NCT04016584 Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy Status COMPLETED Phase NA
NCT04004988 A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants Status COMPLETED Phase PHASE1
NCT04004611 A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) Status COMPLETED Phase PHASE2
NCT04003896 A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma Status TERMINATED Phase PHASE2
NCT03997981 Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) Status RECRUITING Phase N/A
NCT03997448 Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 Status TERMINATED Phase PHASE2
NCT03994796 Genetic Testing in Guiding Treatment for Patients With Brain Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03994627 Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma Status APPROVED_FOR_MARKETING Phase N/A
NCT03988114 A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer Status WITHDRAWN Phase PHASE4
NCT03988088 A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine Status COMPLETED Phase PHASE1